Interreg VI news

INTERREG VI

Interreg

Deutschland-Nederland

Tumorceldetectie in lymfeknopen

Tumorcelldetektion in Lymphknoten

As part of the project Tumor Cell Detection in Lymph Nodes, a better method for detecting lymph node metastases will be developed and validated to allow better staging of the patient. The current TRL level of this subproject is at TRL level 4, and will increased to TRL-7 in parallel with the Cell Puncher Pro project.
The current TRL6 level of the puncher system, the pump-unit system and the disposable items ready for counting tumor cells from the lymph node on a chip and to isolate them for genetic analysis.

The new project is sustainable and will ensure regional employment in the five Dutch and German SMEs, who jointly develop and later produce parts of the Cell Puncher Pro product platform. This side project is actually a second demonstrator for the developed products.

Lymph node metastases are among the major prognostic factors in various types of cancer (including head and neck cancer, prostate cancer and breast cancer). With the current diagnostics, individual tumor cells and (micro-) metastases in a lymph node are overlooked and the patient can be mistakenly classified as lymph node negative (pN0). If this classification is wrong, the patient will receive a less effective treatment with worse outcomes.

Project
Information

Planned project costs

253.036,56 €

Project Duration

1.1.2020 - 31.12.2021

Priority

Increase of cross-border innovation in the programme area

Lead Partner

VyCAP B.V.

Project partners

Universitätsklinikum Düsseldorf,

Project
Financing

Financer Amount
Universitätsklinikum Düsseldorf 64.732,13 €
Provincie Overijssel 5.778,43 €
VyCAP B.V. 50.837,49 €
EFRE / EFRO 144.460,78 €
Ministerie van Economische Zaken en Klimaat 8.667,65 €
MWIDE NRW 14.446,08 €